REMEDENT USA INC/AZ
10QSB, EX-27, 2000-11-20
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: REMEDENT USA INC/AZ, 10QSB, 2000-11-20
Next: MERRILL LYNCH SENIOR FLOATING RATE FUND II INC, SC 13E4/A, 2000-11-20


WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This  schedule  contains  summary  financial   information  extracted  from  the
consolidated  balance sheet and  consolidated  statement of  operations  for the
quarter  ended  September 30, 2000 and is qualified in its entirety by reference
to such financial statements.
</LEGEND>
<CIK>                         0001078037
<NAME>                        REMEDENT USA, INC.
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S. DOLLARS

<S>                           <C>
<PERIOD-TYPE>                                  3-MOS
<FISCAL-YEAR-END>                              MAR-31-2000
<PERIOD-START>                                 JUL-01-2000
<PERIOD-END>                                   SEP-30-2000
<EXCHANGE-RATE>                                1.000
<CASH>                                         19854
<SECURITIES>                                   0
<RECEIVABLES>                                  19254
<ALLOWANCES>                                   (3000)
<INVENTORY>                                    112594
<CURRENT-ASSETS>                               203448
<PP&E>                                         58811
<DEPRECIATION>                                 32533
<TOTAL-ASSETS>                                 257410
<CURRENT-LIABILITIES>                          921305
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       12883
<OTHER-SE>                                     (676778)
<TOTAL-LIABILITY-AND-EQUITY>                   257410
<SALES>                                        221459
<TOTAL-REVENUES>                               221459
<CGS>                                          76283
<TOTAL-COSTS>                                  394398
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             95444
<INCOME-PRETAX>                                (344666)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (344666)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (344666)
<EPS-BASIC>                                    (0.03)
<EPS-DILUTED>



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission